• Thiazovivin (A5506): ROCK Inhibitor Workflow

  2026-08-19

  Thiazovivin is a ROCK inhibitor for workflows that require improved cell recovery after dissociation and support during fibroblast reprogramming or induced pluripotent stem cell generation. This article provides handling and QC guidance while distinguishing product specifications from workflow recommendations; it is for research use only, not diagnostic or therapeutic use.

• TDP-43 Oligomerization, RNA Binding, and Aggregation

  2026-08-18

  The reference study separates two TDP-43 failure modes—loss of oligomerization and loss of RNA binding—and shows that they produce different aggregate locations and formation pathways. Its combination of structure-based variants, human neurons, near-physiological expression systems, and proteasome-impairment experiments provides a mechanistic framework for interpreting heterogeneous TDP-43 pathology in ALS and FTLD.

• CA-074 Me for Cathepsin B and Lysosomal Assays

  2026-08-18

  CA-074 Me is a membrane-permeable cathepsin B inhibitor for separating lysosomal protease activity from upstream cell-death signaling. This practical guide connects LMP imaging, necroptosis workflows, apoptosis assay design, and TNF-α-induced liver injury research with product-specific handling and troubleshooting.

• JNJ-10198409: PDGF Receptor Inhibitor Workflows

  2026-08-17

  JNJ-10198409 is a nanomolar ATP-competitive tool for dissecting PDGF-BB receptor signaling in proliferation, angiogenesis, cancer, and fibrotic disorder models. This practical guide connects dose-response design with time-resolved phosphorylation, phenotype, and troubleshooting workflows.

• Norovirus Co-opts NINJ1 for Selective Secretion

  2026-08-17

  Song et al. show that murine norovirus uses the host membrane-rupture protein NINJ1 to release the viral NS1 protein during caspase-3-dependent cell death. The work connects apoptosis, unconventional protein secretion, and enteric viral pathogenesis, while providing a framework for testing how NINJ1 controls cargo release.

• Staurosporine: From Kinase Probe to Cancer Strategy

  2026-08-16

  Staurosporine is more than a classic apoptosis trigger: its broad kinase activity can help translational researchers test how signaling networks connect tumor-cell survival, ERM-driven invasion, and VEGF-associated angiogenesis—provided its interpretive limits are built into the experimental design.

• GPNMB Model Predicts ESCC Immunotherapy Response

  2026-08-15

  This study identifies circulating soluble GPNMB as a functional marker of resistance to PD-1 blockade in esophageal squamous cell carcinoma. By integrating plasma GPNMB, CAF–epithelial niche features, and clinicopathological data, the authors develop a multimodal framework that links tumor–immune biology with treatment-response prediction.

• Etoposide (VP-16) for DNA Damage Assays

  2026-08-14

  Etoposide (VP-16) provides a practical way to create controlled topoisomerase II–dependent DNA damage for cytotoxicity, apoptosis, and repair-pathway studies. This guide connects dose selection and assay troubleshooting with a senescence-focused reference model, helping researchers distinguish DNA damage, cell death, and senomorphic responses.

• Chloroquine in Cancer Therapy: Pharmacology and Evidence

  2026-08-14

  The 2024 review by Liu and colleagues synthesizes how Chloroquine suppresses tumor progression through both autophagy-dependent and autophagy-independent mechanisms. Its main practical contribution is to connect lysosomal pharmacology with apoptosis, necroptosis, signaling modulation, combination therapy, and the safety constraints that shape clinical translation.

• Vancomycin and the Immune–Microbiome Translation Gap

  2026-08-13

  Vancomycin offers a precise bacterial cell wall perturbation for resistance and microbiome research, but translating antibiotic-associated immune findings requires disciplined controls. This article connects peptidoglycan precursor binding with the Th1/Th2 and gut-flora findings reported in an allergic rhinitis rat study while defining a practical path toward more interpretable translational experiments.

• Step Biosensor Tracks Native Protein Dynamics

  2026-08-13

  The reference study introduces circStep, an allosteric genetically encoded biosensor that converts endogenous protein binding into fluorescence from a dual-locked fluorogenic RNA aptamer module. This design enables live-cell visualization of native protein abundance, localization, and relocalization without directly tagging or overexpressing the protein of interest.

• Prednisolone Workflows for Glucocorticoid Research

  2026-08-12

  Prednisolone provides a high-purity synthetic glucocorticoid control for dissecting receptor signaling, inflammatory phenotypes, and cellular responses alongside emerging ERAD-based degradation assays. This workflow-focused guide shows how to use it as a pathway comparator without mistakenly treating it as the desonide-derived ERAD warhead described in the reference study.

• Gepotidacin (GSK2140944) Research Workflows

  2026-08-12

  Gepotidacin enables mechanism-led antibacterial research from bacterial growth inhibition to DNA gyrase cleavage assays. This workflow connects dose-response screening, resistance analysis, and translational interpretation while emphasizing compound handling and assay troubleshooting.

• AZD0156: A Translational Strategy for ATM Inhibition

  2026-08-11

  AZD0156 offers a highly selective way to interrogate ATM kinase biology, connect DNA double-strand break repair with metabolic adaptation, and design more informative combination studies in cancer therapy research.

• STT3B, ICG, and α-Amanitin Cytotoxicity

  2026-08-11

  The reference study combines a genome-wide CRISPR knockout screen, computational drug screening, and validation in cells, liver organoids, and mice to identify STT3B as a critical determinant of α-amanitin toxicity. Its findings position indocyanine green as a candidate STT3B inhibitor and provide a mechanistic framework for studying mushroom toxin cytotoxicity beyond direct RNA polymerase II inhibition.

17130 records 1/1142 page Next 12345 下5页 Last page